Researchers employed the STING-specific antagonist SN-011 in mice with ischemic stroke induced by middle cerebral artery occlusion, resulting in reduced early inflammation and improved stroke pathology through altered phagocyte activity that supports myelin regeneration (66). The gene discussed is STING1; the disease is ischemic stroke.